Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Yuka Kitamura"'
Autor:
Hirotaka Matsumoto, Hiroaki Akamatsu, Nobuyuki Yamamoto, Yuki Sato, Daichi Fujimoto, Yoshihiko Taniguchi, Motohiro Tamiya, Yasuhiro Koh, Junya Fukuoka, Hisashi Tanaka, Naoki Furuya, Ryota Shibaki, Tsukasa Nozawa, Akira Sano, Yuka Kitamura, Takashi Kijima, Toshihide Yokoyama, Satoru Miura, Akito Hata, Jun Sugisaka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background In small-cell lung cancer (SCLC), the tumor immune microenvironment (TIME) could be a promising biomarker for immunotherapy, but objectively evaluating TIME remains challenging. Hence, we aimed to develop a predictive biomarker of immunoth
Externí odkaz:
https://doaj.org/article/6255e060953c4901b89e6055b35b9eff
Autor:
Akira Naomi, Hideyuki Hujiwara, Tatsuhiko Koizumi, Yukari Sakurai, Yasuo Kohashi, Yukiko Yoneda, Yuka Kitamura, Yoshinobu Hattori, Yuji Saitou
Publikováno v:
Respirology Case Reports, Vol 10, Iss 8, Pp n/a-n/a (2022)
Abstract Cases of upper tracheal stenosis due to cervical schwannoma are fairly rare; therefore, no treatment has been determined. In this case, our patient had been treated for asthma for 4 years and was admitted to our hospital because of exacerbat
Externí odkaz:
https://doaj.org/article/6a2d668077584d5aac21444e9fc298ce
Autor:
Yuka Kitamura, Kousuke Uranishi, Masataka Hirasaki, Masazumi Nishimoto, Ayumu Suzuki, Akihiko Okuda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract A non-canonical PRC1 (PRC1.6) prevents precocious meiotic onset. Germ cells alleviate its negative effect by reducing their amount of MAX, a component of PRC1.6, as a prerequisite for their bona fide meiosis. Here, we found that germ cells p
Externí odkaz:
https://doaj.org/article/e5725950dfaa4ffa90fb9e62a661d97f
Autor:
Mariko Kogo, Daichi Fujimoto, Kazutaka Hosoya, Kazuma Nagata, Atsushi Nakagawa, Ryo Tachikawa, Daisuke Yamashita, Yuka Kitamura, Yukihiro Imai, Keisuke Tomii
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Recent studies indicate the benefit of treatment with osimertinib over that with conventional epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) for untreated EGFR-mutated non-small cell lung cancer (NSCLC).
Externí odkaz:
https://doaj.org/article/9bae2343ecdf421e9d97e6eabc6487fb
Autor:
Yoshiaki Zaizen, Yasuo Kohashi, Kishio Kuroda, Kazuhiro Tabata, Yuka Kitamura, Akira Hebisawa, Yuji Saito, Junya Fukuoka
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background Increasing evidence indicates the utility of transbronchial lung cryobiopsy (TBLC) for the diagnosis of interstitial lung disease (ILD). However, only one study has compared TBLC and surgical lung biopsy (SLB) performed on the sam
Externí odkaz:
https://doaj.org/article/6540307947c246e1a108da3ab07f01b1
Autor:
Yoshiaki Zaizen, Yuki Kanahori, Sousuke Ishijima, Yuka Kitamura, Han-Seung Yoon, Mutsumi Ozasa, Hiroshi Mukae, Andrey Bychkov, Tomoaki Hoshino, Junya Fukuoka
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 709 (2022)
The histopathological diagnosis of mycobacterial infection may be improved by a comprehensive analysis using artificial intelligence. Two autopsy cases of pulmonary tuberculosis, and forty biopsy cases of undetected acid-fast bacilli (AFB) were used
Externí odkaz:
https://doaj.org/article/85b17e98b490411e88f89a13744c26c0
Autor:
Jun Amaki, Hiromichi Matsushita, Yuka Kitamura, Ryoko Nagao, Hiromichi Murayama, Minoru Kojima, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 14-17 (2016)
We experienced the case of a 56-year-old male with B-lymphoid/myeloid lineage mixed phenotype acute leukemia (MPAL). A cytogenetic analysis of the patient's bone marrow revealed a complex karyotype, including der(9)t(7;9)(q11.2;p13). We identified an
Externí odkaz:
https://doaj.org/article/6eb55791fc97443cb84bb85a777f33cf
Autor:
Sayuri Nakamura, Kentaro Hayashi, Yuki Imaoka, Yuka Kitamura, Yuko Akazawa, Kazuhiro Tabata, Ruben Groen, Tomoshi Tsuchiya, Naoya Yamasaki, Takeshi Nagayasu, Junya Fukuoka
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186192 (2017)
Programmed cell death ligand-1 (PD-L1) expression may predict the response to both programmed cell death-1 and PD-L1 inhibitors in lung cancer. However, the extent of intratumoral heterogeneity of PD-L1 expression, which may cause false negative resu
Externí odkaz:
https://doaj.org/article/cf6d7115f7da423d9fae7687059c1452
Autor:
Fumiaki Koizumi, Tomohide Tamura, Kazuhisa Takahashi, Fumiyuki Takahashi, Yoshiharu Maeda, Tatsu Shimoyama, Yuka Kitamura, Takeshi Sawada, Yusuke Nakadate, Ryo Ko, Satoru Kitazono, Yu Fujita, Shigehiro Yagishita
(A) WB analysis of HER2 expression after exposure of the indicated SCLC cells to CDDP at IC10 and IC50 concentrations for the indicated times. (B) WB analysis of HER2 expression after exposure of SBC-3 and SBC-5 cells to ETP and CPT-11 at their IC50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43c7d67ec3bbefd59ea15501d6dffa5
https://doi.org/10.1158/1535-7163.22501128.v1
https://doi.org/10.1158/1535-7163.22501128.v1
Autor:
Fumiaki Koizumi, Tomohide Tamura, Kazuhisa Takahashi, Fumiyuki Takahashi, Yoshiharu Maeda, Tatsu Shimoyama, Yuka Kitamura, Takeshi Sawada, Yusuke Nakadate, Ryo Ko, Satoru Kitazono, Yu Fujita, Shigehiro Yagishita
WB analysis for downstream intracellular signaling of HER2 after exposure to CDDP (IC50 concentration), trastuzumab (1 μg/ml), and CDDP plus trastuzumab.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa81377fb6c3a5f9634fc726bc772b49
https://doi.org/10.1158/1535-7163.22501125
https://doi.org/10.1158/1535-7163.22501125